Ceccato F,Barbot M,Albiger N,Zilio M,De Toni P,Luisetto G .2016 .Long-term glucocorticoid efect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur J Endocrinol, 175(2) : 101-6.
El-Maouche D,Collier S,Prasad M,Reynolds JC,Merke DP .2015 .Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf), 82(3) : 330-7.
Raizada N,Jyotsna VP,Upadhyay AD,Gupta N. .2016 .Bone mineral density in young adult women with congenital adrenal hyperplasia. Indian J Endocrinol Metab, 20(1) : 172283-8210.
Halper A,Sanchez B,Hodges JS,Kelly AS,Dengel D,Nathan BM .2018 .Bone mineral density and body composition in children with congenital adrenal hyperplasia. Clin Endocrinol (Oxf), 88(6) : 13580-9.
Seibel MJ,Cooper MS,Zhou H .2013 .Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. Lancet Diabetes Endocrinol, 8587(13) : 70045-7.
Chen JF,Lin PW,Tsai YR,Yang YC,Kang HY .2019 .Androgens and androgen receptor actions on bone health and disease: From androgen deficiency to androgen therapy. Cells, 8(11) : 1318.
Metwalley KA,El-Saied AR .2014 .Bone mineral status in Egyptian children with classic congenital adrenal hyperplasia. A singlecenter study from Upper Egypt. Indian J Endocrinol Metab, 18(5) : 139236-8210.
Ganesh R,Suresh N,Janakiraman L .2018 .Bone mineral content and density in Indian children with congenital adrenal hyperplasia. Indian Pediatr, 55(10) : 880-2.
Zimmermann A,Sido PG,Schulze E,Al Khzouz C,Lazea C,Coldea C .2008 .Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy. Clin Endocrinol (Oxf), 03518(4) : 2265-84.
Frey KR,Kienitz T,Schulz J,Ventz M,Zopf K,Quinkler M. .2018 .Prednisolone is associated with a worse bone mineral density in primary adrenal insuficiency. Endocr Connect, 7(6) : 811-8.
Arisaka O,Hoshi M,Kanazawa S,Numata M,Nakajima D,Kanno S .2001 .Efect of adrenal androgen and estrogen on bone maturation and bone mineral density. Metab Clin Exp, 50 : 377-9.
Rehman Q,Lane NE .2003 .Efect of glucocorticoids on bone density. Med Pediatr Oncol, 41(3) : 212-6.
Fleischman A,Ringelheim J,Feldman H,Gordon C .2007 .Bone mineral status in children with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab, 20(2) : 227-35.
Merke DP,Bornstein SR,Avila NA,Chrousos GP .2002 .Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med, 136(4) : 200202190-34.
de Almeida Freire PO,de Lemos-Marini SH,Maciel-Guerra AT,Morcillo AM,Matias Baptista MT,de Mello MP .2003 .Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density. J Bone Miner Metab, 21(6) : 396-401.
Manolagas SC,O'Brien CA,Almeida M. .2013 .The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol, 9(12) : 699-712.
Garcia AJ,Schueftan DL,de Mendonça LM,Farias ML,Beserra IC .2014 .Bone mineral density in children and adolescents with congenital adrenal hyperplasia. Int J Endocrinol, : 2F806895.
Ünal S,Alikaşifoğlu A,Özön A,Gönç N,Kandemir N. .2020 .Efect of longterm glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia. Turk J Pediatr, 03(3) : 359-66.